HOME › DRUGS › DEPEMOKIMAB
ACTIVE SUBSTANCE / INN

DEPEMOKIMAB

Brand name(s): Exdensur
EMA LISTED
AUTHORISED
Asthma;Nasal Polyps
ACTIVE SUBSTANCE
Depemokimab
REGULATORS
EMA
SPONSORS / MAH
GlaxoSmithKline Trading Services Limited
TOTAL APPLICATIONS
1
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
ExdensurGlaxoSmithKline Trading Services LimitedAuthorised12/02/2026Asthma;Nasal Polyps

FULL INTELLIGENCE ON DEPEMOKIMAB

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →